President Trump Links Tylenol and Vaccines to Autism, Drawing Medical Community's Rebuke
President Donald Trump has suggested unproven links between Tylenol, vaccines, and autism, prompting swift criticism from medical experts.
During a White House press conference on September 22, 2025, President Donald Trump suggested that the use of Tylenol (acetaminophen) during pregnancy and the administration of vaccines may be linked to autism. He advised pregnant women to avoid Tylenol and proposed altering standard vaccination schedules, despite a lack of supporting medical evidence.
Medical experts swiftly criticized these assertions. The American College of Obstetricians and Gynecologists labeled the claims as "irresponsible," emphasizing the absence of credible evidence connecting Tylenol or vaccines to autism. Tylenol manufacturer Kenvue also refuted the alleged link, cautioning that avoiding the medication could lead to the use of less safe alternatives. Following the President's remarks, Kenvue's stock experienced a significant decline.
In the same press conference, the Food and Drug Administration announced plans to explore the approval of leucovorin, a folic acid derivative, as a potential treatment for autism-related folate deficiencies. While preliminary studies have shown some promise, researchers stress the necessity for larger, more rigorous trials to confirm efficacy.
The administration's statements have raised concerns among health professionals about the dissemination of misinformation and its potential impact on public health practices.